Share Information & SEC Filings
This page is intended for investors and commercial partners.
Mereo BioPharma share price and SEC Filings
Whether you are a portfolio manager, analyst or retail investor, this page equips you with the insights to assess Mereo’s market position and strategic direction. Nasdaq MREO share data provides real-time information about the price of Mereo stock. Records of all SEC filings deliver on our commitment to transparency and operational discipline, while delivering value for investors.
MREO Nasdaq Share Data
| Price (USD) | $0.42 |
| Change | $0.00 |
| Volume | 322,163 |
| %Change | 0.00% |
| Intraday High | $0.44 |
| 52 Week High | $3.26 |
| Intraday Low | $0.41 |
| 52 Week Low | $0.20 |
| Today's Open | 0.42 |
| Previous Close | $0.42 |
SEC Filings
| Filing Date | Form Type | Description | Filing Group | Downloads |
|---|---|---|---|---|
| 11/02/2022 | SC 13G/A | An amendment to the SC 13G filing | Other | |
| 11/02/2022 | SC 13G/A | An amendment to the SC 13G filing | Other | |
| 13/01/2022 | S-8 | Securities offered to employees pursuant to employee benefit plans | Registration Statements | |
| 22/12/2021 | 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | Current Reports | |
| 02/12/2021 | SC 13G | A statement of beneficial ownership of common stock by certain persons | Other | |
| 30/11/2021 | 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | Current Reports | |
| 04/11/2021 | 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | Current Reports | |
| 02/11/2021 | 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | Current Reports | |
| 26/10/2021 | 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | Current Reports | |
| 26/10/2021 | 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | Current Reports |
